Skip to content

Dimethyltryptamine levels in blood of schizophrenic patients and control subjects

B. Angrist, S. Gershon, G. Sathananthan, R. W. Walker, B. Lopez-Ramos, L. R. Mandel, W. J. A. Vandenheuvel

Psychopharmacology 1976 DOI: 10.1007/bf00428697 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Population Normal controls and schizophrenic patients
Topics DMT 5-MeO-DMT
Keywords Blood levels Schizophrenia Assay
Citations 44
Key findings Mean DMT levels were not statistically significantly different between schizophrenic patients and controls, despite apparent elevations in certain subgroups.

Abstract

A gas chromatographic-mass spectrometric determination of blood N,N-dimethyltryptamine in normal controls and schizophrenic patients was carried out with a sensitivity limit of 0.05 ng/ml whole blood. Although the results appear to suggest that the mean DMT level was higher in the total patient group, those patients with acute psychosis, female patients and patients with suspiciousness scores on the BPRS of 4 or over, the differences were not statistically significant.

Comparable studies

Other observational and cohort studies on DMT, most cited first.

Citations in the library

Explore topics